Zetia & Vytorin: how Merck got patients to spend $21 billion on drugs that don’t work | The Ethical Nag
Links shared publicly online about this topic.
- 136total visits
Zetia & Vytorin: how Merck got patients to spend $21 billion on drugs that don’t work | The Ethical Nag
View full resource at ethicalnag.org
Tags: Cholesterol Medication, Drug, Vytorin, Zetia, Merck & Co.
Most Recently Shared on July 19, 2011 at 6:08 am By:
Zetia & Vytorin: how Merck got patients to spend $21 billion on drugs that don't work - http://t.co/DTf5XgW
Sage Advice On Vytorin - Forbes
forbes.com — “So what is the bottom line on the continuing kerfluffle over the cholesterol drugs Zetia and Vytorin, sold by Merck? The basic problem is this: What should patients and doctors do when insufficient data is collected on a new medicine? Merck has lots of studies showing that Zetia lowers cholesterol, but [...]” View full resource at forbes.com
Most Recently Shared on March 29, 2012 at 12:10 pm By:
Since it came up today, here's what I still think is the bottom line on Zetia. http://t.co/3tv3VyCW
Comments of migraine in the use of Crestor - eHealthMe.com
ehealthme.com — “I currently taking crestor and zetia to lower my cholestoral 10mg each. But every since i have been taking them I have been getting these horible migraines every single day. no over the counter meds have helped. I have been taking the meds for a yr now and I never had a problem until i refilled. I am wondering if i got a bad bottle. because it is horrible..” View full resource at ehealthme.com
Most Recently Shared on March 15, 2012 at 10:31 pm By:
I currently taking crestor and zetia to lower my cholestoral 10mg each. But every since i have been taking the http://t.co/C361xTDu
F.D.A. Rejects Merck’s Application for Combination Drug - NYTimes.com
nytimes.com — “The proposed new drug would combine Merck’s drug Zetia, which lowers “bad” cholesterol, with the generic version of Lipitor, the statin made by Pfizer.” View full resource at nytimes.com
Most Recently Shared on March 7, 2012 at 5:57 pm By:
David Rubin Internist, Physician, and Doctor
Kind of sad, and I'm glad the FDA rejected it. Effectively saying they think Lipitor is better than Zocor (their drug!) http://t.co/Vl6DuWcv
FDA allows Vytorin labeling for use in kidney disease, but not new indication
nephrologynews.com — “FDA did not approve a new indication for Vytorin or for Zetia” View full resource at nephrologynews.com
Most Recently Shared on January 27, 2012 at 3:56 pm By:
Nephrology News Health News and Nephrology
FDA allows Vytorin labeling for use in kidney disease, but not new indication http://t.co/oMlX4LMD
Zetia: still crazy after all these years « White Coat Underground
whitecoatunderground.com — “Zetia: still crazy after all these years « White Coat Underground” View full resource at whitecoatunderground.com
Most Recently Shared on November 17, 2011 at 12:09 am By:
PalMD Doctor, Internist, and Physician
Zetia: still crazy after all these years http://t.co/3bYH4zfp @matthewherper FYI
Zetia: still crazy after all these years « White Coat Underground
whitecoatunderground.com — “Zetia: still crazy after all these years « White Coat Underground” View full resource at whitecoatunderground.com
Most Recently Shared on November 17, 2011 at 12:07 am By:
PalMD Doctor, Internist, and Physician
Zetia: still crazy after all these years http://t.co/OqFr7voN
Pfizer Tries to Block Merck Pill - WSJ.com
online.wsj.com — “Pfizer, facing the loss of its U.S. monopoly for its cholesterol-lowering treatment Lipitor, is trying to block an attempt by Merck to sell a pill that combines a generic version of Lipitor with Merck's Zetia.” View full resource at online.wsj.com
Most Recently Shared on October 11, 2011 at 9:25 pm By:
drmintz Doctor, Internist, and Physician
Not helping @PhRMA 's case about putting patients ahead of profits RT @Loftus: Pfizer Tries to Block Merck Pill http://t.co/78VWufG7
RxEconsult, LLC - Vytorin (ezetimibe/simvastatin) for cholesterol reduction
rxeconsult.com — “RxEconsult, LLC - Vytorin (ezetimibe/simvastatin) for cholesterol reduction” View full resource at rxeconsult.com
Most Recently Shared on September 20, 2011 at 11:58 am By:
RxEconsult. If you are in need of healthcare services or information, please visit RxEconsult.
Dr. Ogbru received his Doctorate in Pharmacy from the University of the Pacific School of Pharmacy in 1995. He completed a Pharmacy Practice Residency at the University of Arizona/University Medical Center in 1996. He was a Professor of Pharmacy Practice and a Regional Clerkship Coordinator for the University of the Pacific School of Pharmacy from 1996-99.
Dr. Ogbru has written several journal articles. In 1997, he shared an award from the American Journal of Pain Management for Outstanding Contribution to the Interdisciplinary Pain Management Literature. Over the last 12 years Dr. Ogbru has held several roles in the pharmaceutical industry, including Director of Global Medical Information and Communication." /> Ome Ogbru, PharmD Active Health Library, Doctor, Pharmacist, and PharmD
Microsoft Word - 20049393-1294072-pi.doc
ofr.gov — “Microsoft Word - 20049393-1294072-pi.doc” View full resource at ofr.gov
Most Recently Shared on September 7, 2011 at 1:36 pm By:
RT @eyeonfda: #FDA sets 11/2 AdComm Date on Merck's sNDA for Zetia and Vytorin 2 reduce CV in CKD patients - http://ow.ly/6nFRY $MRK
Personal Health: News and Notes - Philly.com
articles.philly.com — “A cholesterol-lowering drug faces more questions Yet another study questions the value of the cholesterol-lowering drug ezetimibe, marketed by Merck as Zetia.Previously, two major clinical trials” View full resource at articles.philly.com
Most Recently Shared on May 30, 2011 at 10:56 am By:
Urology & Nephrology OW Health
Personal Health: News and Notes: Yet another study questions the value of the cholesterol-lowering drug ezetimib... http://bit.ly/iOAJeM
Abbott’s Ticking Time Bomb - Matthew Herper - The Medicine Show - Forbes
blogs.forbes.com — “On Thursday, Abbott Laboratories' heart drugs Tricor and TriLipix will face an FDA advisory panel which will examine how the medicines should be used given the lack of evidence for them. Although this controversy has flown under the radar compared to the one that hit Merck's Zetia a few years [...]” View full resource at blogs.forbes.com
Most Recently Shared on May 17, 2011 at 2:45 pm By:
Drugs and Devices OW OW Health
Abbott's Ticking Time Bomb: Controversy is brewing on Abbott's triglyceride lowering drug. http://onforb.es/lsZomE #drug
Advertising a different way to fight cholesterol - but without evidence on big outcomes - Gary Schwitzer's HealthNewsReview Blog
healthnewsreview.org — “Advertising a different way to fight cholesterol - but without evidence on big outcomes - Gary Schwitzer's HealthNewsReview Blog” View full resource at healthnewsreview.org
Most Recently Shared on April 7, 2011 at 6:39 pm By:
A is for ad (see it at http://ht.ly/4vyne). Z is for Zetia. O is for outcomes that really matter.
MediGuard.org - Zetia
mediguard.org — “MediGuard.org - Zetia” View full resource at mediguard.org
Most Recently Shared on January 31, 2011 at 6:17 pm By:
MediGuard.org Health Organization
100% of patients taking #zetia use it for High Cholesterol ... http://tinyurl.com/47ryqx7
Merck Settles Patent Infringement Case For Zetia(R) (ezetimibe)
medicalnewstoday.com — “Merck & Co., Inc. and Glenmark Pharmaceuticals Inc., USA and Glenmark Pharmaceuticals, Ltd. have reached an agreement to settle their patent litigation involving Glenmark's challenge to Merck's pa” View full resource at medicalnewstoday.com
Most Recently Shared on May 11, 2010 at 11:11 pm By:
MNT Pharma News Health News and Pharma
Merck Settles Patent Infringement Case For Zetia(R) (ezetimibe) http://mnt.to/3CsX #pharma #pharmaceutical
Advertisement
